Fibroblasts from human spleen regulate NK cell differentiation from blood CD34+ progenitors via cell surface IL-15

被引:64
作者
Briard, D
Brouty-Boyé, D
Azzarone, B
Jasmin, C
机构
[1] Hop Paul Brousse, INSERM, U268, F-94807 Villejuif, France
[2] Hop Paul Brousse, Inst Andre Lwoff, Unit506, Villejuif, France
关键词
D O I
10.4049/jimmunol.168.9.4326
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Besides a structural role in tissue architecture, fibroblasts have been shown to regulate the proliferation and differentiation of other neighboring specialized cell types, but differently according to the anatomic site and pathologic status of their tissue of origin. In this study we report a novel regulatory function of human spleen-derived fibroblasts in the development of NK cells from adult resting blood progenitors. When CD34(+) cells were cocultured with spleen-derived fibroblasts in monolayers, nonadherent CD56(+)CD3(-) NK cells were predominantly produced after 2-3 wk of culture in the absence of exogenous cytokines. Most NK cells expressed class I-recognizing CD94 and NK p46, p44, and p30 receptors as well as perforin and granzyme lytic granules. Moreover, these cells demonstrated spontaneous killing activity. Cell surface immunophenotyping of spleen-derived fibroblasts revealed a low and consistent expression of IL-15, Flt3 ligand, and c-kit ligand. Additionally, low picogram amounts of the three cytokines were produced extracellularly. Neutralizing Abs to IL-15, but not the other two ligands, blocked NK cell development. Additionally, suppressing direct contacts of CD34+ progenitors and fibroblasts by microporous membrane abrogated NK cell production. We conclude that stromal fibroblasts within the human spleen are involved via constitutive cell surface expression of bioactive IL-15 in the development of functional activated NK cells under physiologic conditions.
引用
收藏
页码:4326 / 4332
页数:7
相关论文
共 34 条
  • [1] Mechanisms of cytokine production by fibroblasts - Implications for normal connective tissue homeostasis and pathological conditions
    Apte, RN
    [J]. FOLIA MICROBIOLOGICA, 1995, 40 (04) : 392 - 404
  • [2] Brouty-Boyé D, 2000, EUR J IMMUNOL, V30, P914, DOI 10.1002/1521-4141(200003)30:3<914::AID-IMMU914>3.3.CO
  • [3] 2-4
  • [4] Effects of human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues on CD34+ stem cells
    Brouty-Boyé, D
    Briard, D
    Azzarone, B
    Le Bousse-Kerdilès, MC
    Clay, D
    Pottin-Clémenceau, C
    Jasmin, C
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (04) : 484 - 488
  • [5] Brouty-Boyé D, 1998, INT J CANCER, V76, P767, DOI 10.1002/(SICI)1097-0215(19980529)76:5<767::AID-IJC24>3.0.CO
  • [6] 2-#
  • [7] FIBROBLAST-MEDIATED DIFFERENTIATION IN HUMAN BREAST-CARCINOMA CELLS (MCF-7) GROWN AS NODULES IN-VITRO
    BROUTYBOYE, D
    MAINGUENE, C
    MAGNIEN, V
    ISRAEL, L
    BEAUPAIN, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (05) : 731 - 735
  • [8] Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation
    Buckley, CD
    Pilling, D
    Lord, JM
    Akbar, AN
    Scheel-Toellner, D
    Salmon, M
    [J]. TRENDS IN IMMUNOLOGY, 2001, 22 (04) : 199 - 204
  • [9] Carayol G, 1998, EUR J IMMUNOL, V28, P1991, DOI 10.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO
  • [10] 2-7